Detalhe da pesquisa
1.
Detection of duodenal villous atrophy on endoscopic images using a deep learning algorithm.
Gastrointest Endosc
; 97(5): 911-916, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36646146
2.
Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease.
Int J Colorectal Dis
; 38(1): 54, 2023 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36840779
3.
Disease recurrence in patients with Crohn's disease after biologic therapy or surgery: a meta-analysis.
Int J Colorectal Dis
; 37(10): 2185-2195, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36149447
4.
Correction to: Disease recurrence in patients with Crohn's disease after biologic therapy or surgery: a meta-analysis.
Int J Colorectal Dis
; 37(12): 2547, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334110
5.
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Gut
; 63(4): 567-77, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23468464
6.
Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection.
Visc Med
; 40(2): 82-91, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584858
7.
Treatment Strategies in Inflammatory Bowel Diseases.
Dtsch Arztebl Int
; 120(45): 768-778, 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37408514
8.
[Fecal microbiota transplantation: indications, risks and opportunities]. / Fäkaler Mikrobiomtransfer Indikationen, Risiken und Chancen.
Inn Med (Heidelb)
; 63(10): 1036-1042, 2022 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-36053300
9.
Intestinal Wnt in the transition from physiology to oncology.
World J Clin Oncol
; 13(3): 168-185, 2022 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35433295
10.
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression.
Clin Transl Gastroenterol
; 13(1): e00450, 2022 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029158
11.
Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial.
Trials
; 23(1): 173, 2022 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35193638
12.
Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Digestion
; 84(1): 29-35, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21304239
13.
Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells.
Dis Model Mech
; 14(1)2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33293281
14.
Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
Am J Gastroenterol
; 105(8): 1811-9, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20197757
15.
Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn's disease and active smoking status resulting in ileal stenosis requiring surgery.
PLoS One
; 15(7): e0236421, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32716958
16.
The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγânull Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab.
Inflamm Bowel Dis
; 26(4): 557-569, 2020 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31782956
17.
Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
Am J Gastroenterol
; 104(7): 1737-44, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19455118
18.
rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
Am J Gastroenterol
; 104(3): 665-72, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19262523
19.
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Inflamm Bowel Dis
; 14(4): 437-45, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18088064
20.
Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.
Inflamm Bowel Dis
; 21(10): 2327-40, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26263469